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This paper outlines information and advice on how a practitioner can formally pursue research pertaining 
to herbal or complementary medicine. It recommends five practical steps: get advice and acquire skills, 
find out what other people have done already, consider what research you want to do, decide on a design 
and finalise a detailed research plan. Enrolling in a postgraduate research degree program is 
recommended as a way to acquire basic research skills and obtain support for an initial project. 
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Introduction 
Many health practitioners have at some time 
contemplated the idea of undertaking research. The 
thought may remain a passing desire to investigate 
a question or may develop into a passion to 
undertake research. Herbal medicine (HM) and 
complementary medicine (CM) research is still in 
its infancy in Australia and some practitioners may 
lack confidence in converting their curiosity or 
interest. The current paper offers suggestions on 
where and how to get started. It suggests five initial 
steps: get advice and acquire skills, find out what 
other people have done already, consider what 
research you want to do, decide on a design and 
finalise a detailed research plan.  
The paper particularly focuses on obtaining 
research training and on studies that involve human 
or animal participants. It is important to recognise 
that other legitimate research foci, e.g. a study of 
historical developments, philosophy of science or 
sociocultural study, may require different 
methodologies than are described here. 
1.  Get advice and acquire skills 
Starting a research project is very challenging if a 
practitioner does not have research training and 
experience. There are traps for the unwary and it is 
wise to begin by collaborating with experienced 
researchers. This not only helps practitioners to 
complete a high quality project, it also provides 
skills they can take to future research.  
If the practitioner can find an established researcher 
who shares their ideas and would like to 
collaborate, this may provide sufficient support. 
However if the project is not a central priority for 
the collaborator it may be difficult to ensure that 
long term support is obtained. There is a better 
chance of ensuring other demands do not take 
priority if a collaborator is a supervisor in a tertiary 
program since this produces an obligation to 
provide satisfactory support to a project’s 
completion. The obligation is underpinned by 
institutional procedures that help ensure that this 
occurs.  
Professional training programs often include a 
research component and that may be sufficient to 
meet the needs of many practitioners who wish to 
do research but do not plan a research career. 
However the best way to obtain a coherent and 
substantial program of research training is to 
undertake a postgraduate research degree. These 
programs offer sustained support, systematic 
research training and practical resources (internet, 
library, laboratory, office and equipment access, 
and usually financial assistance). Satisfactory 
completion of a postgraduate program provides 
credibility as a researcher, potentially opening 
additional career options and enhancing ability to 
obtain research funding.  
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The vision of completing a substantial research 
project and thesis can be daunting to prospective 
researchers. However projects can be broken into 
achievable sub-tasks that progressively build skills. 
These sub-tasks progress from a brief description of 
initial ideas, refinement of a literature review and 
research proposal and detailed planning, to the 
conduct, analysis and write up of one or more 
projects. An increasingly popular way to break 
tasks into discrete units that offer clear deadlines 
and sequential achievements is to divide a 
postgraduate program into a set of peer reviewed 
journal papers. There are many advantages in this 
approach. The discipline of a strict maximum word 
length for an article keeps reviews and research 
descriptions succinct and gives valuable experience 
in research writing. Progressive publications ensure 
that the researcher has an early impact on the field 
and a series of well received papers opens 
additional opportunities (e.g. scholarships or travel 
grants and subsequent employment or research 
funding). Detailed feedback from reviewers alerts 
the researcher to limitations, often in time for 
modifications to projects or their write up. In 
essence, reviewers supplement the advisory team 
offering independent advice. Acceptance of papers 
in peer reviewed journals also makes it difficult for 
subsequent markers to criticise the thesis severely, 
especially if the journals have a high profile. 
Publications also provide concrete rewards for the 
advisory team. In many universities, candidates can 
even choose to submit a set of papers (usually with 
the addition of an introduction and a commentary) 
in place of a traditional thesis.  
Fulfilling criteria to enter a postgraduate 
research program 
Some universities allow direct entry to a 
postgraduate research program with a pass 
undergraduate degree plus practice experience. 
However most require applicants for Doctor of 
Philosophy (PhD) programs to have a strong 
undergraduate honours degree (e.g. Honours I or 
IIA/II-1) or its equivalent (e.g. a Masters degree). 
That program must usually include a substantial 
research project. Since universities differ in their 
entry requirements, it is important to consult 
websites of universities under consideration.  
Even if a university requires more research 
experience for entry, applicants with a pass degree 
and strong grades may be able to enter a PhD 
program after completing a one year honours 
qualification. If an applicant holds an honours or 
Masters qualification that does not quite meet 
requirements for direct PhD entry (e.g. an 
insufficient research component or an insufficient 
grade of honours), entry to a Master in Philosophy 
(MPhil) program may be an option. Provided 
progress targets are met, universities typically 
provide for a subsequent application to transfer to 
the doctoral program. This pathway has the 
advantage of requiring a shorter period of initial 
commitment and it does not necessarily extend the 
overall time to attain a doctorate, since research 
before transferring to a PhD can be counted. 
Choosing a university  
Any university is a potential option since all have 
potential supervisors for most projects. However 
there are advantages in finding a university with 
research groups that have similar interests to your 
own. Currently in Australia, CM research groups 
are at Southern Cross University, the Universities 
of New England, Western Sydney, Queensland and 
Sydney, and at RMIT. The research expertise of a 
university need not be specifically in herbal 
medicine. It may be in a specific research technique 
or area of research. Universities, schools and 
research centres all have areas of particular strength 
or priority. A particularly strong and successful 
research group may not always be the best current 
fit to the early researcher’s needs, for example the 
student can sometimes have fierce competition for 
advisor time.  
Choice of a research context should also include 
ready access to library or other resources, required 
equipment or laboratory facilities, and an available 
research population.  
Another important criterion in choosing a university 
is access. The researcher needs ready access to the 
advisory team and resources, which is enhanced by 
a shorter distance from the home or workplace. The 
university may allow students to undertake 
postgraduate research at a distance, and a 
combination of electronic communication and face 
to face visits can support some projects. Distance 
does magnify logistical challenges, and there are 
minimum requirements for on site study over the 
program.  
Most students find that on site location is 
particularly helpful when planning research, 
submitting a proposal, undertaking statistical 
analyses and finalising their thesis.  
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Selecting an advisory team 
Engaging an effective advisory team is critical 
when starting research, regardless of whether it 
involves postgraduate study. Advisors as a group 
must have the skills and commitment to you and 
your project to provide optimal assistance. If the 
research closely matches the specific interests and 
skills of at least one advisor, you can have greater 
confidence that they will share your enthusiasm, be 
aware of developments in the field and help you 
maximise the quality and impact of your project.  
If you enrol for a research degree, the primary 
advisor must have an honorary or substantive post 
in the university you are enrolling in and hold at 
least the qualification level they are supervising. 
Since there is a paucity of HM or CM academics 
with doctoral degrees, it may be challenging to find 
people from those fields who fulfil this 
requirement. Associate advisors can typically be 
appointed on practice skills alone, and in some 
cases a team may need to be from more than one 
university. The university will require at least one 
advisor who has an employment contract that 
extends as long as your expected candidature, so 
you can be assured of supervision continuity.  
A good supervisor must not only have relevant 
interests and skills, but must also be able to work 
with the student. In a doctoral degree this will be a 
long term partnership. An effective relationship and 
generic skills in supervision can be more important 
than obtaining a perfect match of interests. 
Supervisors vary in skills as educators, supervision 
styles and even commitment. Some are more 
demanding, some more empathic and some are 
better at meeting particular needs (e.g. literature 
review, project management, statistical analysis, 
writing or developing independence). Some 
supervisors are more effective at particular stages 
of the program. You both need to decide whether 
there is a close enough match for both needs. You 
may find it useful to talk to previous supervisees, 
while appreciating that their experience might not 
be the same as your own. You will need to become 
comfortable with this person, to feel safe to talk 
about research problems and admit to ignorance 
and perceived mistakes, if you are to gain the most 
benefit from the relationship. If problems do 
develop in the relationship, universities have staff 
who can help resolve the issues and if necessary 
change your advisory team. 
In many cases specific needs emerge during 
research which are optimally addressed by people 
outside the advisory team. You may attend training 
at other places (e.g. on specific techniques), briefly 
visit other researchers or ask questions by phone or 
email. These contacts not only enrich your training, 
they can also prove useful in finding sympathetic 
markers and identifying potential referees for 
employment applications.  
How to apply for entry 
Enrolment in a research degree typically requires 
only the completion of enrolment and research 
proposal forms. Forms and procedures vary 
between universities but you may be asked to 
outline reasons for undertaking the program, 
describe a research question, outline current 
relevant literature and a proposed project, identify 
likely resource requirements and set a time frame 
for completion. Typically you are asked only for a 
few paragraphs on each issue, and these are 
tentative responses. It is understood that projects 
often change dramatically over subsequent months.  
A Master of Philosophy requires at least 12 months 
of full time enrolment but usually takes 18-24 
months depending on topic and progress. A PhD 
typically requires at least 3 years of full time 
enrolment with most people needing 3.5 to 4 years. 
Universities vary in maximum lengths of 
candidature but all strongly encourage completion 
of a Masters degree within 2 years and a PhD 
within 4 years. In Australia postgraduate research 
programs are exempt from fees, and tax free 
scholarships are available on a competitive basis. In 
other countries fees are usually payable but in some 
cases a scholarship to waive fees or offer a stipend 
may be available.  
Part time enrolment may be the only viable option 
for many practitioners. The upside is that this is 
likely to provide more income during the research 
program. The downside is that it extends 
completion times and poses challenges in 
maintaining motivation and the project’s novelty. If 
the research idea has commercial potential, patents 
may be taken by others if preparatory studies are 
delayed. Part time enrolment also poses challenges 
for time management and places higher demands on 
recreational time and on the family. Successful part 
time study requires that employment hours and 
duties are compatible with requirements of the 
research. One way to accomplish compatibility is to 
undertake a project that fits into priorities of the 
workplace and that uses its facilities or clients. 
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2.  Find out what other people have 
done already 
The fact that someone else may have already 
looked at your area of interest may not matter. 
Often your question is not the same as theirs or on 
careful reading you notice ways you could answer 
the question more effectively. However it is 
important to know where other researchers have 
reached and identify minimum standards and 
accepted procedures for research in the area.  
While an internet search can be a rich source of 
information, it is difficult to judge its quality and 
much will be missed if that is the only source. Peer 
reviewed journals offer an assurance of quality, and 
library search engines (e.g. Medline) offer a 
powerful method to locate publications. Not all HM 
journals are listed in these databases and even the 
most careful search can miss a key paper. Located 
papers are supplemented by a careful review of 
their reference lists.  
As an initial strategy carefully read recent reviews 
of the area - these provide an orientation to current 
questions and methodology. You will need to 
develop your own view of the issues rather than 
rely on insights of others. Reviews reflect both 
strengths and the weaknesses of current ideas and 
major advances often require a fresh look at the 
issues and evidence. Reviewers may miss or 
misinterpret papers and their conclusions will not 
always mirror your own. 
It is a good idea to write down initial ideas to help 
structure early discussions with your advisor. These 
notes should not only summarise the papers you 
read, but also include ideas about questions or 
potential research studies and outline arguments 
about key issues. At first they may be random dot 
points, but as ideas develop a more formal review 
of the area should be undertaken. You may consider 
publishing this review (or parts of it) to stake your 
claim as a prospective contributor to the field. If 
you are undertaking a research degree a review is 
required for confirmation of candidature and 
acceptance of the research prospectus. It also 
constitutes a draft of the thesis introduction. 
3.  Consider what research you want 
to do 
There are three key questions to ask when choosing 
a research question and developing a preliminary 
plan. 
(a)  Are you enthusiastic about the idea? 
Whether the research is part of a tertiary program or 
not, it will last some time and has costs attached 
(e.g. time, opportunities, financial). At some points 
you will probably be frustrated by it or will wish it 
were over. Your excitement and curiosity about the 
idea must be enough to sustain you through these 
periods.  
(b)  Will this research make a difference?  
Is the idea novel? Is the problem that it addresses an 
important one? Will this research provide a 
substantial contribution to our understanding of the 
problem, or to clinical practice? Are there ways the 
idea could be modified to increase its impact? What 
would happen if this research were never done? 
Enthusiasm for an idea can blind researchers to its 
arcane or even trivial nature. The views of others 
provide a more objective assessment of 
significance. While innovations in theory and 
practice are sometimes undervalued by others who 
are committed to existing notions, a consensus that 
a project has low potential impact is usually 
correct. At least one advisor should share your faith 
in your project’s significance. 
(c)  Is it feasible? 
Can the project be completed in the available time? 
Does the research team have the skills to complete 
it or access to ways of developing those skills? Can 
you obtain required participants? Can you access 
equipment, space or other resources to complete it?  
A critical criterion is how a high quality piece of 
work can be finished within the required time frame 
with minimal pain. As an idea develops it often 
becomes too complicated or ambitious and needs to 
be scaled back. Rigorous analysis of each element 
is needed. It is important to remember that a 
university program provides training for research 
rather than constituting your life’s work.  
Feasibility (and advisor enthusiasm) can be 
enhanced by undertaking a project that interfaces 
closely with other research by an advisor. When 
considering this as an option you need to ensure 
that you will be able to ‘own’ a clearly defined and 
agreed aspect as your own (e.g. for your thesis and 
for publication or patent). If there are several 
investigators on their advisor’s project, it is 
important to ensure that all investigators agree to 
the division of intellectual property. A further 
consideration is that you need to be sure that there 
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are no potential problems in the associated project 
that would put your own at risk. 
4.  Decide on a design 
Different designs answer different questions about 
the area of interest. Each has strengths but also has 
limitations and implications for feasibility. 
Consideration of designs helps to refine the 
research question further.  
Basic laboratory research 
Basic research may be descriptive (e.g. a chemical 
analysis of different herbal preparations), but more 
typically involves manipulating a variable of 
interest while keeping other aspects constant (e.g. 
observing in vitro reactions of an HM constituent in 
a control and experimental cell line). Laboratory 
based research allows substantial experimental 
control but typically requires well developed skills 
in using specialised equipment and procedures. 
This sometimes requires completion of a 
preliminary course or may involve on site training 
by a technician.  
Cross sectional studies 
These studies examine responses at one point in 
time (e.g. community attitudes to natural therapies 
or research on current practices). Often these 
involve examining characteristics associated with 
particular behaviours, attitudes or treatment 
outcomes. Such studies are usually easier to 
conduct than ones that follow the same people 
through time. It is hard to determine causal 
relationships if there is only one occasion of 
measurement and no attempt at experimental 
manipulation. An association between positive 
attitudes to herbal medicine and its impact might be 
because respondents were pleased with its effect, or 
positive health outcomes may be due to the attitude 
(e.g. a placebo response), or both may be due to a 
third factor (e.g. greater commitment to health 
maintenance). 
Longitudinal studies 
Longitudinal studies repeatedly assess the same 
sample over time, e.g. examining outcomes of 
treatments. Longitudinal designs allow researchers 
to disentangle directions of influence. If 
participants had positive attitudes to HM before 
receiving it and these attitudes did not subsequently 
change, the attitudes were not caused by the HM. 
These designs also allow researchers to measure 
and partial out effects of confounding variables.  
A longer duration of follow up provides greater 
confidence that effects are maintained, but also 
delays completion of the project and minimising 
dropouts can be challenging. If lost participants are 
not included the study’s results can be misleading 
(e.g. if results of a trial only included people who 
stayed in a study because it was effective, the study 
would overestimate its effectiveness). While 
statistical procedures can deal with dropouts (and 
dropout can itself be an outcome), lost data is 
ambiguous (e.g. participants may not return because 
they have recovered or because they are not 
receiving benefit) and estimations are at best an 
intelligent guess. It is important to find ways to 
retain participants (e.g. requesting multiple contact 
methods or providing incentives). 
A simple predictive study can be highly compatible 
with routine clinical practice. Requirements include 
a standard assessment protocol, information about 
treatment and high follow up rates. Responses to 
treatment may be predicted from initial assessments 
conducted or from measures during treatment (e.g. 
adherence).  
Treatment outcome trials 
A subset of longitudinal designs involves 
comparing treatments. At its simplest level this 
comprises a study of outcomes on one or more 
uncontrolled case or a program evaluation. The 
latter is essentially a predictive study on a specific 
program. A limitation of uncontrolled case studies 
is that they cannot directly test whether participants 
would have recovered anyway, or whether effects 
differ from alternative treatments.  
A quasi-experimental design gives different 
treatments to subsets of participants without 
random assignment. Some may wait for a treatment 
or receive standard care, however the lack of 
random assignment means that differential 
outcomes may be due to pre-existing 
characteristics.  
A type of quasi-experimental design that offers 
greater confidence in results involves ‘single case’ 
or ‘N = 1’ methodology. These designs study one 
case or a small number of cases in detail and retain 
flexibility in the delivery and refinement of 
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treatment during the study. They all require 
repeated (if not continuous) assessment including 
one or more baseline or control period, and need 
stability in the dependent measure. An example is 
an ABA, Return-to-Baseline or Reversal design, 
where a control intervention (A) is alternated with 
an experimental intervention (B). If on return to the 
control intervention a measure (e.g. side effect 
level) returns to its original level, the researcher can 
have confidence that a change from the active 
intervention was not simply due to elapsed time. 
More than one reversal of the conditions (e.g. 
ABAB) gives more faith in the attribution of effects 
to the experimental condition, rather than for 
example coincidental change in other factors. An 
example could involve testing hawthorn (Crataegus 
oxycantha) extract vs. placebo in people with high 
blood pressure. Blood pressure would be tested 
repeatedly through the study. Responses to 
successive periods of placebo and hawthorn extract 
could be examined. Versions of this design involve 
more than one active treatment (e.g. ABAC or 
ABCBC where C is an additional active treatment).  
An ABA design relies on a clear cut response 
emerging during the treatment phase and at least 
partial reversion to previous status during the 
repeated baseline. If the treatment has lasting 
effects (e.g. sustained recovery occurs), ABA 
effectively becomes an uncontrolled case study. It 
may be ethically inappropriate to withdraw 
treatment to see a replicated effect (e.g. where a 
problem is potentially life threatening).  
Another single case design has multiple baselines 
where a treatment is progressively given to 
different individuals, or in different contexts, and 
controls continue to receive a baseline until it is 
their turn to receive treatment. A wait list design is 
like a multiple baseline applied to two randomly 
allocated groups where one group waits before it 
receives the experimental treatment. In the single 
case version, two or more individuals progressively 
obtain the treatment. A requirement is that 
treatment of one person (or treatment in one 
setting) does not affect the remainder. This can be 
difficult with some treatments (e.g. where 
meditation is the CM, a patient may talk about the 
skill with another who is waiting). Since the 
baseline of the last person or context continues until 
all previous ones receive treatment, this can involve 
an extensive baseline if there are many people or 
contexts. There are many other single case designs 
and combinations are possible (e.g. multiple 
baseline plus ABA).  
Randomised controlled trials (RCTs) allocate 
participants into groups using random numbers or 
permutations, sometimes controlling for particular 
characteristics (e.g. gender). With sufficient 
numbers, randomisation makes it likely that 
conditions will be roughly matched on potentially 
confounding characteristics, although this matching 
cannot be guaranteed especially in studies with 
small to medium size (e.g. ≤ 50 participants). 
For the development of medicines research is 
conventionally divided into phases. Phase I trials 
involve preliminary tests of safety and side effect 
profiles, physiological responses and appropriate 
doses in a small sample who are examined 
intensively. Phase II trials examine the feasibility of 
a treatment outcome trial testing beneficial and 
negative effects of the medicine and refining 
information about effective doses. Phase I and II 
trials are typically multiple case studies or quasi-
experiments although some Phase II trials may have 
a small scale randomised design (offering a short 
term pilot for a Phase III trial). Phase III trials are 
usually large scale RCTs on the new treatment, 
comparing it with control interventions (e.g. a 
current standard treatment). Phase IV trials examine 
effects and risks of the treatment in routine 
practice. While the phases were identified primarily 
with synthetic medicines in mind, they are equally 
applicable to HM.  
An additive design can be used to test combinations 
of interventions. An advantage of this approach is 
that a combination of interventions better reflects 
CM practice. It is also possible to determine 
whether combinations of interventions (e.g. HMs) 
are more effective than a monotherapy. An example 
of a 4 week RCT exploring HM in the treatment of 
insomnia could involve participants being 
randomised to placebo, valerian (Valeriana off.), or 
to valerian plus hops (Humulus lupulus). The trial 
may even have a fourth group receiving an 
individualised herbal formula. Significant 
methodological and logistical challenges may be 
encountered. Since differences between effects of 
active treatments may be small, large numbers of 
patients may be required to obtain a statistically 
significant difference between those interventions. 
This is costly and requires more resources and time 
than a comparison with placebo or wait list 
conditions (where differences in effect are typically 
larger). In the above case if numbers were 
insufficient, active treatments may show superior 
effects to placebo, but no significant differences 
between them may be observed.  
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Whole systems research  
RCTs on a single treatment or constituent are 
commonly regarded by the orthodox medical 
community as the ‘gold standard’ measure to 
determine evidence of efficacy (Pirotta 2007). 
Many caveats exist when applying a reductive 
model to determine efficacy of CM. Practitioners of 
phytotherapy and CM use individualised 
prescriptions to treat the “whole” person (mind-
body and interconnected systems). This holistic 
practice cannot be adequately explored via trials 
that reduce the intervention to a single mono-
therapy or isolated constituent. While complex or 
multicomponent therapies (e.g. Maizels 2004) and 
global subjective measures of quality of life or 
similar concepts are commonly evaluated in RCTs, 
these designs still typically apply standard 
protocols across individuals and look for average 
effects. 
The construct of ‘whole systems research’ has been 
developed to meet the shortcomings of reductive 
research and better test and understand practice of 
CM (Ritenbaugh 2003).  
This individualised approach can be applied within 
controlled designs (including N = 1 designs), but 
more often use naturalistic, multiple case studies. 
These studies are subject to all the limitations of 
uncontrolled case studies that were identified above 
(e.g. confounding with natural recovery and 
placebo effects) and they cannot identify which 
aspects of a complex intervention were responsible 
for an effect or how they worked. If conducted by a 
single practitioner these studies are also 
confounded with practitioner skill or other 
individual characteristics. However a substantial 
body of case studies from multiple treatment 
centres provides robust preliminary support for a 
particular practice.  
A middle ground between a phased approach to 
refinement of interventions and a whole systems 
approach can be found. For example decision rules 
about individual tailoring of treatments can be 
formulated and progressively refined during a study 
so that the process of individualisation can be 
reported and potentially replicated by others.  
Questions about specific contributions of 
components, including the decision rules and the 
presence of individualisation, can then be 
progressively tested within standard controlled 
trials.  
Qualitative methodology 
Qualitative approaches to research provide an 
opportunity to derive rich, detailed 
information about individual experience and 
are particularly useful where little is known 
about the phenomenon or where a focused 
quantitative approach may miss critical issues. 
For example views of doctors about CM or HM 
might be canvassed (e.g. Miha 2007) or decision 
making about CM examined (e.g. Caspi 2002). 
Qualitative approaches all tend to ask individuals or 
focus groups a set of open ended questions and then 
derive categories or themes from the transcripts. 
Many use a grounded theory approach (Glaser 
1967). Commonly independent raters look for 
categories or themes from the responses, followed 
by a process of checking for consistency 
(sometimes including a statistical report of inter-
rater reliability). Further transcripts are obtained 
and reviewed until no new themes emerge 
(redundancy is reached). Higher order categories 
may then be derived (usually by consensus between 
raters). Studies with higher research quality may 
have fidelity raters to confirm the categories, ask 
the respondents whether categories and themes 
accurately reflect their views and examine whether 
rater biases affected the results. Reports of 
qualitative studies typically report both the themes 
and quotations (exemplars) to clarify their meaning. 
Derivation of themes may be undertaken by hand, 
or be assisted by software such as NUD*IST© 
(Richards 2002, now superseded by NVIVO7
©
), 
which help record categories and their hierarchies. 
Researchers considering qualitative measurement 
should remember that the formulation of questions 
and collection of data can be relatively easy, but 
derivation of themes can be extremely time 
consuming. For this reason the number of questions 
should be kept to a minimum. Since closed 
questions can affect open ended responses, where 
researchers want to use a combination of 
questionnaires and qualitative analyses, closed 
questions on a similar topic should be administered 
after a qualitative measure. 
Qualitative methods are excellent for development 
of hypotheses and for understanding phenomen-
ological experience or examining salient attitudes 
or beliefs. Impressions of the importance or 
frequency of themes can be obtained within these 
approaches but the methodology is not intended to 
provide quantitative data. Subsequent research with 
focused, quantitative methods (e.g. giving the same 
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closed question to all participants) is advised for the 
measurement of frequency or intensity (e.g. of a 
side effect or reason for HM use). 
Mixed methodology research 
To better assess efficacy and treatment outcomes, 
controlled mixed method designs can be 
implemented using a combination of qualitative and 
quantitative assessments (Verhoef 2007). The 
strength of combining these methodological 
approaches includes the ability to assess efficacy 
(quantitative) as well as exploring the healing 
experience (qualitative). Augmentation of an RCT 
with qualitative assessment also explores areas that 
may not yet be uncovered. For example an RCT 
could involve testing over 4 weeks the hypnotic 
effect of valerian against placebo in subjects with 
insomnia. Quantitative measures may include sleep 
latency and hours slept. Qualitative assessment may 
involve a semi-structured interview asking 
questions such as ‘What has been your personal 
experience of taking the tablets?’.  Responses may 
identify as yet undetected benefits or side effects. 
These phenomena could be used to derive 
hypotheses for further test in a subsequent study.    
The importance of qualitative data is highlighted by 
the fact that researchers’ preconceptions often 
retard the development of medical advances - the 
delay in acceptance of Heliobactor pylori is an 
example (Kavanagh 2007). Many significant 
advances in orthodox pharmaceuticals, including 
lithium carbonate and Viagra
©
, were the result of 
serendipitous patient reports (Kavanagh 2007).  
5.  Finalise a detailed research plan 
Obtain access to resources 
Access to space and to financial or other resources 
should be obtained early in the planning process 
and formal approval and scheduling must be in 
place before the research schedule is finalised. 
Potential threats to resources need to be considered 
(e.g. not receiving a scholarship, equipment being 
updated or recalibrated, competing clinical 
demands or competing projects) and contingency 
plans need to be put in place for significant risks. 
Choose measures 
A review of potential assessment measures should 
ensure that they are reliable, valid and (in a 
longitudinal study) sensitive to change. They 
should reach international standards and be readily 
accepted by high quality journals in the area. You 
should ensure the assessment measures are readily 
available, any required training in using these can 
be accessed and their cost is within budget. For a 
treatment trial a ready supply of the intervention 
e.g. herb/s or nutrient/s (and if applicable placebo) 
needs to be identified. You may have to wait for 
project approval by relevant institutions and ethics 
committees before equipment, measures or 
medicines are obtained and delivery times can be 
extensive, especially if items are sourced from 
overseas or require special production (e.g. 
placebos matching the HM in appearance). 
Determine the required sample  
In research involving human or animal participants, 
the sample of participants should be representative 
of the population you wish to study. While it is 
tempting to limit criteria for inclusion to ensure a 
relatively homogeneous sample, greater restrictions 
can pose problems for recruitment and limits the 
ability to generalise to a general population (e.g. 
regular clinic attendees).  
Representativeness and confidence in a study’s 
conclusions are influenced by the number of 
participants in a study. This number depends on the 
study’s design, whether measures are continuous or 
categorical (e.g. improved/not improved) and how 
large an effect is expected. There are readily 
available computer programs that can help you 
calculate sample size, some of which are free  
(e.g. GPower, www.psycho.uni-duesseldorf.de/ 
abteilungen/aap/gpower3/).  
If you do not have training in experimental design 
and analysis, it may be wise to seek statistical 
advice before deciding on sample size. Three 
concepts are required to calculate and interpret 
power analyses. Alpha (α) is the chance that there is 
really no difference between the averages, 
proportions or correlations you may obtain. The 
standard maximum is .05, i.e. we tolerate making 
this error no more than 5% of the time. Power is the 
chance that we will detect a true effect with this 
sample size - here the standard minimum is .80 (i.e. 
we want to detect a true effect at least 80% of the 
time). You may sometimes see power expressed as 
1-β (beta is the risk of missing a true effect). The 
third concept is effect size. This is the size of the 
minimum difference you want to be able to detect. 
For a test of a difference between two averages, this 
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may be expressed in standard deviation units which 
adjust for the degree of spread around different 
averages. Required sample sizes increase 
dramatically as effect sizes decrease. For example 
for two groups studied on one occasion, 14 
participants are needed in each group to detect 1 
standard deviation difference between averages, 
with α = .05 and Power = .80. However 51 are 
needed in each group if you want to detect a half 
standard deviation difference. Differences in effects 
between two active treatments (e.g. as in the 
previous valerian vs. valerian plus hops example) 
are often less pronounced and hence larger sample 
sizes are required.  
Finalise plans to obtain participants 
How easy it is to recruit human participants will 
depend on the number who fulfil inclusion criteria 
in the potential catchment area, ease of accessing 
them and the project’s attractiveness (e.g. potential 
treatment benefits or other incentives). Recruiting 
people for a project involves similar marketing 
skills that practitioners use to attract clients to their 
business. In clinical trials one strategy is to engage 
potential referral agents such as clinics. The 
research should interface with the interests and 
strategic priorities of the referral agency, for 
example it should not reduce the earnings of a 
private practice by taking away patients. Rather it 
should fill an unmet need or provide a competitive 
edge.  
As with individual participants, agencies are more 
likely to participate if the project involves low cost 
(e.g. minimal staff time and inconvenience) and 
provides significant perceived benefit. Discussions 
with the practice manager and key practitioners 
may reassure them that these criteria are satisfied. 
Permission can then be sought to send posters, 
flyers or referral letters. In some circumstances the 
clinic may agree to researchers screening 
consenting patients or contacting practitioners at 
regular intervals to ask about potential referrals. 
Direct marketing to potential participants may be 
undertaken through electronic and print media, 
provided that community volunteers are suitable for 
the study. While recruitment cannot begin until 
ethical clearances are obtained, preliminary plans 
for marketing, including timing of media campaigns 
and preparation of draft press releases can be 
undertaken earlier. 
Obtain ethical clearances 
When conducting research that involves humans or 
animals, an ethics proposal needs to be submitted to 
be considered a recognised committee of the 
institution where the research will be sited. Ethical 
review confirms that risks of harm, discomfort and 
inconvenience are minimised and expected benefits 
are sufficient to compensate for any negative 
effects that might occur. In Australia ethical 
guidelines can be accessed from the National 
Health and Medical Research Council website 
(www.nhmrc.gov.au). Human ethical guidelines 
have recently been revised (NHMRC 2007). 
If a project is across more than one institution, it 
must be considered by all committees unless there 
is an overarching committee for multiple sites. 
Committees may have separate forms for 
completion although attempts are being made to 
standardise formats. If the research is being 
conducted in a health facility, but is part of a 
university program, a university committee 
typically considers it after approval by the relevant 
health service committee. Approval can take as 
little as a week after submission (in the case of 
some uncomplicated projects, especially with prior 
approval by another committee), or can stretch over 
several months. It is wise to submit proposals at the 
earliest possible stage to avoid delay. 
While key foci for an ethics committee are the risks 
and participant rights, a consideration of benefits 
may involve a subcommittee examining the 
methodology and feasibility of the research to 
ensure that benefits are likely. Ethical approval in a 
health service may also require assurance of 
approved service access. It is therefore wise to gain 
in principle support for the project from a 
managerial gatekeeper before submitting the 
proposal. 
Develop a list of tasks and a schedule for 
completion 
Treat the research project like a building 
construction. Identify the major tasks, who will do 
them and how long they will take, and create a 
graphical schedule. Allow for unforeseen delays 
and avoid ambitious estimates of time frames. 
While the schedule will need to be modified as the 
project progresses, creating it will highlight 
potential problems and periods where greater time 
investment will be needed. 
Aust J Med Med Herbalism 20(1) 2008 
 
 
 
 
26 
Conclusion 
With good advice and with careful planning and 
preparation, getting started on a research project 
can readily be broken into small, achievable steps. 
Converting initial curiosity into action is an 
exciting venture. We hope that many readers of this 
paper will catch the excitement and take the plunge.  
Further reading 
University study: Details on how to make the most 
of supervision and successfully complete 
postgraduate research can be obtained on many 
university websites. 
Single case designs: For details on how to choose 
and conduct this type of study consult a relevant 
text (e.g. Kratochwill 1992). 
Quantitative research design: Hart (2003) provides 
a brief paper on the challenges of determining a 
question and design for a herbal medicine trial.  
Qualitative research: A brief review of qualitative 
methods in psychology is given by Silverstein, 
Auerbach and Levant (2006). Texts include Patton 
(2002), and Strauss & Corbin (1990). 
Mixed method designs: See reviews such as 
Verhoef, Casebeer & Hilsden (2002). 
Research in CAM (Adams 2007): Leading 
researchers provide excellent insight into various 
forms of research as they apply to CAM.  
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